𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

✍ Scribed by Robert P. Perrillo; Hie-Won Hann; Eugene Schiff; David Mutimer; Bernard Willems; Nancy Leung; William M. Lee; Susan Dixon; Mary Woessner; Carol L. Brosgart; Lynn D. Condreay; Stephen D. Gardner

Book ID
107593919
Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
309 KB
Volume
5
Category
Article
ISSN
1936-0533

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liver transplantation for chronic hepati
Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine
✍ Chung Mau Lo; Chi Leung Liu; George K. Lau; See Ching Chan; Irene O. Ng; Sheung πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 95 KB

Lamivudine treatment in patients with chronic hepatitis B virus (HBV) infection may improve clinical state and suppress viral replication before liver transplantation. Emergence of lamivudine-resistant YMDD mutant is common. We report the results of liver transplantation in 16 patients with pretrans

Increased risk of adefovir resistance in
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
✍ Yoon-Seon Lee; Dong Jin Suh; Young-Suk Lim; Suk Won Jung; Kang Mo Kim; Han Chu L πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 239 KB

Although adefovir dipivoxil (ADV) has a unique profile of delayed and infrequent resistance in treatment-naΓ―ve chronic hepatitis B patients, the association of ADV resistance with previous lamivudine (LAM) resistance is not well understood. We compared the emergence of the ADV-resistant mutations rt

Mutations associated with the therapeuti
Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis
✍ Kazuyoshi Ohkawa; Tetsuo Takehara; Michio Kato; Aimi Kanada; Matsuo Deguchi; Mas πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 269 KB

## Abstract Factors influencing the therapeutic efficacy of adefovir dipivoxil added to continuing lamivudine have not been elucidated in lamivudine‐resistant patients with type B chronic hepatitis. The viral mutations influencing the efficacy of treatment with adefovir dipivoxil were investigated